Patients for Affordable Drugs Now, INC.

Patient group advocating for lower prescription drug prices.

Based in DC

🤖

AI Overview

With $320K in lobbying spend across 18 quarterly filings, Patients for Affordable Drugs Now, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2022.

$320K
Total Spend
5
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$80K
2019$80K
2020$80K
2021$80K
2022$0

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

  • H.R. 1892 - Bipartisan Budget Act of 2018, Omnibus.
  • S. 974 - Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act).
  • H.R. 2051 - Fair Access for Safe and Timely Generics A
  • S. 974 - Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act).
  • H.R. 2051 - Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act of 2017).
  • S. 974 - Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act).
  • S. 974 - Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act)
  • American Patients First (Drug Pricing Blueprint)

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.